The monitoring guidelines raised clinician awareness of issues surrounding proper vancomycin utilization but also raised several questions. Most of the references provided in this article were ...

The vancomycin guidelines chose not to include the possible impact of varying generic products upon efficacy, toxicity or monitoring. There was felt to be insufficient data to make recommendations.